genOway Société anonyme (FRA:JEH)

Germany · Delayed Price · Currency is EUR

2.040

+0.010 (0.49%)

Last updated: Oct 23, 2026, 8:07 AM CEST

Market Cap	20.28M -20.6%
Revenue (ttm)	24.58M -2.2%
Net Income	-2.10M
EPS	n/a
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	400
Open	2.040
Previous Close	2.030
Day's Range	2.040 - 2.040
52-Week Range	2.000 - 2.700
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 24, 2026

About genOway Société anonyme

genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation KI, and quick KI rat models; and customized cell lines, such as constitutive and inducible KO, point mutation KI, reporter KI, quick KI, and KI cell lines. The company also offers humanized immune checkpoi... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1999

Employees 163

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol JEH

Financial Performance

In 2025, genOway Société anonyme's revenue was 26.03 million, an increase of 0.72% compared to the previous year's 25.84 million. Earnings were 927,754, a decrease of -49.32%.

Financial Statements